Page last updated: 2024-11-07

bradykinin, leu(8)-des-arg(9)-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bradykinin, Leu(8)-des-Arg(9)-: RN given refers to (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID123884
CHEMBL ID80472
MeSH IDM0145566

Synonyms (24)

Synonym
CHEMBL80472 ,
gtpl641
[leu8,des-arg9]bradykinin
[leu...8...][des-arg...9...]bradykinin
bradykinin, leucyl(8)-des-arginine(9)-
bradykinin, leu(8) (1-8)
8-leu-9-de-arg-bradykinin
bradykinin, leu(8)-des-arg(9)-
bradykinin, 8-l-leucine-9-de-l-arginine-
8-leu-9-des-arg-bk
NCGC00167253-01
2-{[1-(2-{2-[2-({1-[1-(2-amino-5-guanidino-pentanoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonyl}-amino)-acetylamino]-3-phenyl-propionylamino}-3-hydroxy-propionyl)-pyrrolidine-2-carbonyl]-amino}-4-methyl-pentanoic acid
bdbm50089306
64695-06-3
(2s)-2-[[(2s)-1-[(2s)-2-[[(2s)-2-[[2-[[(2s)-1-[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpe
des-arg9-leu8-bradykinin
b 6769
b-6769 ,
b6769 cpd
(des-arg9,leu8)-bradykinin
(s)-2-((s)-1-((s)-2-((s)-2-(2-((s)-1-((s)-1-((s)-2-amino-5-guanidinopentanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)-3-phenylpropanamido)-3-hydroxypropanoyl)pyrrolidine-2-carboxamido)-4-methylpentanoic acid
DTXSID50983334
n-[{1-[n-(2-{[2-({[1-(arginylprolyl)pyrrolidin-2-yl](hydroxy)methylidene}amino)-1-hydroxyethylidene]amino}-1-hydroxy-3-phenylpropylidene)seryl]pyrrolidin-2-yl}(hydroxy)methylidene]leucine
Q27080258

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Des-Arg9-bradykinin-mediated contractions were inhibited by the specific bradykinin B1 receptor antagonist des-Arg9-[Leu8]bradykinin which produced parallel shifts in the dose-response curve to the selective bradykinin B1 receptor agonist."( Bradykinin B1 receptors in human umbilical vein.
Antúnez, P; Pérez, H; Rothlin, RP; Sardi, SP, 1997
)
0.3
" FR167344 and FR173657 inhibited the B2 receptor-mediated phosphatidylinositol (PI) hydrolysis and produced a concentration-dependent rightward shift in the dose-response curve to bradykinin."( Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657.
Aramori, I; Asano, M; Iwami, M; Kojo, H; Morikawa, N; Nakamura, K; Notsu, Y; O'Donnell, N; Zenkoh, J, 1997
)
0.3
" However, when animals were pre-treated with BCG, the dose-response curves for both B1 agonists were shifted 2 to 8-fold to the left."( Systemic treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG) potentiates kinin B1 receptor agonist-induced nociception and oedema formation in the formalin test in mice.
Calixto, JB; de Campos, RO; Henriques, MG, 1998
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.50120.003245.467312,589.2998AID2517
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
B2 bradykinin receptorHomo sapiens (human)Ki0.01000.00000.70577.6740AID43292
B1 bradykinin receptorHomo sapiens (human)Ki0.38200.00020.09570.3820AID42993
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (25)

Processvia Protein(s)Taxonomy
smooth muscle contractionB2 bradykinin receptorHomo sapiens (human)
inflammatory responseB2 bradykinin receptorHomo sapiens (human)
cell surface receptor signaling pathwayB2 bradykinin receptorHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayB2 bradykinin receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationB2 bradykinin receptorHomo sapiens (human)
blood circulationB2 bradykinin receptorHomo sapiens (human)
response to salt stressB2 bradykinin receptorHomo sapiens (human)
regulation of vasoconstrictionB2 bradykinin receptorHomo sapiens (human)
negative regulation of peptidyl-serine phosphorylationB2 bradykinin receptorHomo sapiens (human)
vasoconstrictionB2 bradykinin receptorHomo sapiens (human)
vasodilationB2 bradykinin receptorHomo sapiens (human)
regulation of vascular permeabilityB2 bradykinin receptorHomo sapiens (human)
arachidonic acid secretionB2 bradykinin receptorHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediatorB2 bradykinin receptorHomo sapiens (human)
intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediatorB2 bradykinin receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayB2 bradykinin receptorHomo sapiens (human)
negative regulation of protein phosphorylationB1 bradykinin receptorHomo sapiens (human)
positive regulation of leukocyte migrationB1 bradykinin receptorHomo sapiens (human)
inflammatory responseB1 bradykinin receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationB1 bradykinin receptorHomo sapiens (human)
protein kinase C-activating G protein-coupled receptor signaling pathwayB1 bradykinin receptorHomo sapiens (human)
response to mechanical stimulusB1 bradykinin receptorHomo sapiens (human)
cell migrationB1 bradykinin receptorHomo sapiens (human)
negative regulation of cell growthB1 bradykinin receptorHomo sapiens (human)
response to lipopolysaccharideB1 bradykinin receptorHomo sapiens (human)
negative regulation of blood pressureB1 bradykinin receptorHomo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolB1 bradykinin receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayB1 bradykinin receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
protease bindingB2 bradykinin receptorHomo sapiens (human)
phosphatidylinositol phospholipase C activityB2 bradykinin receptorHomo sapiens (human)
bradykinin receptor activityB2 bradykinin receptorHomo sapiens (human)
protein bindingB2 bradykinin receptorHomo sapiens (human)
type 1 angiotensin receptor bindingB2 bradykinin receptorHomo sapiens (human)
protein heterodimerization activityB2 bradykinin receptorHomo sapiens (human)
bradykinin receptor activityB1 bradykinin receptorHomo sapiens (human)
protein bindingB1 bradykinin receptorHomo sapiens (human)
peptide bindingB1 bradykinin receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
endosomeB2 bradykinin receptorHomo sapiens (human)
Golgi apparatusB2 bradykinin receptorHomo sapiens (human)
plasma membraneB2 bradykinin receptorHomo sapiens (human)
intracellular membrane-bounded organelleB2 bradykinin receptorHomo sapiens (human)
plasma membraneB2 bradykinin receptorHomo sapiens (human)
endoplasmic reticulumB1 bradykinin receptorHomo sapiens (human)
plasma membraneB1 bradykinin receptorHomo sapiens (human)
plasma membraneB1 bradykinin receptorHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (15)

Assay IDTitleYearJournalArticle
AID43292Ability to bind to human cloned B2 receptor in competition binding experiments with [3H]- bradykinin2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Synthesis and biological evaluation of bradykinin B(1)/B(2) and selective B(1) receptor antagonists.
AID165499Intrinsic activity was determined1981Journal of medicinal chemistry, Dec, Volume: 24, Issue:12
Biological activities of photoaffinity labeling analogues of kinins and their irreversible effects on kinin receptors.
AID167556In vitro 50 % Maximal response in rabbit aorta expressing B1 receptor1981Journal of medicinal chemistry, Dec, Volume: 24, Issue:12
Biological activities of photoaffinity labeling analogues of kinins and their irreversible effects on kinin receptors.
AID42993Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Synthesis and biological evaluation of bradykinin B(1)/B(2) and selective B(1) receptor antagonists.
AID167555Percent agonistic activity in rabbit aorta expressing B1 receptor relative to bradykinin1981Journal of medicinal chemistry, Dec, Volume: 24, Issue:12
Biological activities of photoaffinity labeling analogues of kinins and their irreversible effects on kinin receptors.
AID92422Inhibition of contraction of human umbilical vein (HUV) induced by different concentrations of bradykinin was determined2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Synthesis and biological evaluation of bradykinin B(1)/B(2) and selective B(1) receptor antagonists.
AID92420Ability to inhibit contraction of human umbilical vein (HUV) induced by [des-Arg10]-Kallidin was determined.2000Journal of medicinal chemistry, Jun-15, Volume: 43, Issue:12
Synthesis and biological evaluation of bradykinin B(1)/B(2) and selective B(1) receptor antagonists.
AID1346495Human B1 receptor (Bradykinin receptors)1994The Journal of biological chemistry, Aug-26, Volume: 269, Issue:34
Expression cloning of a human B1 bradykinin receptor.
AID1346532Mouse B1 receptor (Bradykinin receptors)1996Immunopharmacology, Jun, Volume: 33, Issue:1-3
The agonist selectivity of a mouse B1 bradykinin receptor differs from human and rabbit B1 receptors.
AID1346530Rat B1 receptor (Bradykinin receptors)1999European journal of pharmacology, Jun-25, Volume: 374, Issue:3
Molecular characterisation of cloned bradykinin B1 receptors from rat and human.
AID1346495Human B1 receptor (Bradykinin receptors)1997Molecular pharmacology, Feb, Volume: 51, Issue:2
Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657.
AID1346495Human B1 receptor (Bradykinin receptors)1997The Journal of biological chemistry, Apr-25, Volume: 272, Issue:17
Stable expression of the human kinin B1 receptor in Chinese hamster ovary cells. Characterization of ligand binding and effector pathways.
AID1346495Human B1 receptor (Bradykinin receptors)1999European journal of pharmacology, Jun-25, Volume: 374, Issue:3
Molecular characterisation of cloned bradykinin B1 receptors from rat and human.
AID1346532Mouse B1 receptor (Bradykinin receptors)1997Canadian journal of physiology and pharmacology, Jun, Volume: 75, Issue:6
Partial agonists and full antagonists at the human and murine bradykinin B1 receptors.
AID1346495Human B1 receptor (Bradykinin receptors)1997British journal of pharmacology, Sep, Volume: 122, Issue:2
Stable expression of human kinin B1 receptor in 293 cells: pharmacological and functional characterization.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (100)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (6.00)18.7374
1990's61 (61.00)18.2507
2000's22 (22.00)29.6817
2010's11 (11.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.74 (24.57)
Research Supply Index4.63 (2.92)
Research Growth Index5.38 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other102 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]